Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Khiron Life Sciences Corp. (V:KHRN)

Business Focus: Alternative Medicine

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for KHRN within the last 6 months
Loading...
See all filings within the past 6 months

Company News

May 10, 2022 07:15 ET
Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022
In Q1 2022, Khiron expects to surpass 1 million CAD in medical cannabis revenues in the United Kingdom ("UK") aloneTotal untapped potential for cannabis patients in the UK exceeds 1M patientsSupported by its clinic in the UK opened in late 2021, Khiron has increased its sales volumes more than 240% in Q1 2022 compared to entire 2021Khiron's growing portfolio in the UK includes KHIRON 20/1, one of the best-selling THC-predominant cannabis flower in the UK marketTORONTO, May 10, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A
Read full article
May 10, 2022 07:15 ET
Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022
In Q1 2022, Khiron expects to surpass 1 million CAD in medical cannabis revenues in the United Kingdom ("UK") aloneTotal untapped potential for cannabis patients in the UK exceeds 1M patientsSupported by its clinic in the UK opened in late 2021, Khiron has increased its sales volumes more than 240% in Q1 2022 compared to entire 2021Khiron's growing portfolio in the UK includes KHIRON 20/1, one of the best-selling THC-predominant cannabis flower in the UK marketTORONTO, May 10, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC),
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.12
--
--
Price to Sales - TTM
1.90
3.14
6.01
Price to Book - most recent quarter
0.73
1.17
1.77
Price to Cash Flow per share - TTM
--
10.06
9.50
Price to Free Cash Flow per share - TTM
--
9.23
22.85
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Apr 30, 202282,789-154,145
Apr 15, 2022236,93483,510
Mar 31, 2022153,42459,020
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Khiron Life Sciences Corp. is a Canada-based vertically integrated medical cannabis company. The Company has operations in Latin America and Europe. The Company operates through four segments: Health services, Medical cannabis products, Wellbeing products and corporate. The Company provides patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure . The Company sells its products in Colombia, Peru, Germany, United Kingdom and Brazil.

See business summary

 

Twitter

Search (past week) for $KHRN.CA KHRN.V